Beam Therapeutics Inc (BEAM)

NASDAQ · Biotechnology

29.29
+0.27 (+0.93%)
Updated Sep 2, 10:38 PM ET
AI Rating
Hold
Overall Score
61
Trend
57
Momentum
76
Risk
48

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 20, 2025 260 sessions Sep 1, 2026

AI Analysis

Beam Therapeutics Inc is trading at $29.29, up 0.93% on the session. The 50 day average sits at $29.60 and the 200 day at $28.41, which puts the stock in a uptrend. RSI is at 51.5, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $28.67 with resistance near $31.48, so that band frames the current range. Average daily movement is roughly $1.58, or about 5.4% of the share price, which is what any stop placement has to allow for. The overall health score of 61 out of 100 combines a trend score of 57, momentum of 76 and a risk score of 48.

Technical indicators

RSI (14)
51.5
neutral
MACD
0.356
bullish crossover
SMA 20
28.23
SMA 50
29.60
SMA 200
28.41
uptrend
ATR (14)
1.58
avg daily range
Support
28.67
Resistance
31.48
Volume vs 20d
0.53x
below average
Volatility
60.3%
annualised
1 month
+12.00%
3 months
+0.21%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.